HEADER TRANSFERASE 04-DEC-20 7KXN TITLE BTK1 SOAKED WITH COMPOUND 26 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ISOFORM BTK-C OF TYROSINE-PROTEIN KINASE BTK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: AGAMMAGLOBULINEMIA TYROSINE KINASE,ATK,B-CELL PROGENITOR COMPND 6 KINASE,BPK,BRUTON TYROSINE KINASE; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BTK, AGMX1, ATK, BPK; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.VIACAVA FOLLIS REVDAT 2 18-OCT-23 7KXN 1 REMARK REVDAT 1 19-MAY-21 7KXN 0 JRNL AUTH H.QIU,Z.ALI,A.BENDER,R.CALDWELL,Y.Y.CHEN,Z.FANG,A.GARDBERG, JRNL AUTH 2 N.GLASER,A.GOETTSCHE,A.GOUTOPOULOS,R.GRENNINGLOH,B.HANSCHKE, JRNL AUTH 3 J.HEAD,T.JOHNSON,C.JONES,R.JONES,S.KULKARNI,C.MAURER, JRNL AUTH 4 F.MORANDI,C.NEAGU,S.POETZSCH,J.POTNICK,R.SCHMIDT,K.ROE, JRNL AUTH 5 A.VIACAVA FOLLIS,C.WING,X.ZHU,B.SHERER JRNL TITL DISCOVERY OF POTENT AND SELECTIVE REVERSIBLE BRUTON'S JRNL TITL 2 TYROSINE KINASE INHIBITORS. JRNL REF BIOORG.MED.CHEM. V. 40 16163 2021 JRNL REFN ESSN 1464-3391 JRNL PMID 33932711 JRNL DOI 10.1016/J.BMC.2021.116163 REMARK 2 REMARK 2 RESOLUTION. 1.34 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0158 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.34 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 59.35 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 59357 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.167 REMARK 3 R VALUE (WORKING SET) : 0.164 REMARK 3 FREE R VALUE : 0.197 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.200 REMARK 3 FREE R VALUE TEST SET COUNT : 6022 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.34 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.38 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4319 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.56 REMARK 3 BIN R VALUE (WORKING SET) : 0.2830 REMARK 3 BIN FREE R VALUE SET COUNT : 475 REMARK 3 BIN FREE R VALUE : 0.2870 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2182 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 48 REMARK 3 SOLVENT ATOMS : 270 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.35 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.18000 REMARK 3 B22 (A**2) : 0.62000 REMARK 3 B33 (A**2) : -0.80000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.060 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.057 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.042 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.304 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.970 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.959 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2363 ; 0.006 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 2190 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3203 ; 1.110 ; 1.980 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5105 ; 0.632 ; 3.005 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 287 ; 6.078 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 112 ;33.330 ;24.196 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 446 ;12.241 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;14.546 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 336 ; 0.076 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2586 ; 0.009 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 495 ; 0.000 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 2342 ; 8.318 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 41 ;14.442 ; 5.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 2473 ; 6.685 ; 5.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 389 A 481 REMARK 3 RESIDUE RANGE : A 531 A 546 REMARK 3 ORIGIN FOR THE GROUP (A): 16.4555 1.4890 9.2521 REMARK 3 T TENSOR REMARK 3 T11: 0.1348 T22: 0.0560 REMARK 3 T33: 0.1347 T12: 0.0194 REMARK 3 T13: 0.0197 T23: 0.0198 REMARK 3 L TENSOR REMARK 3 L11: 0.3204 L22: 1.3660 REMARK 3 L33: 1.2660 L12: -0.0572 REMARK 3 L13: 0.4515 L23: 0.4340 REMARK 3 S TENSOR REMARK 3 S11: -0.0197 S12: -0.1039 S13: -0.0850 REMARK 3 S21: 0.1388 S22: 0.0387 S23: 0.1184 REMARK 3 S31: 0.2136 S32: -0.0798 S33: -0.0190 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 547 A 560 REMARK 3 ORIGIN FOR THE GROUP (A): 28.4316 18.3919 16.7807 REMARK 3 T TENSOR REMARK 3 T11: 0.0879 T22: 0.1280 REMARK 3 T33: 0.1021 T12: 0.0003 REMARK 3 T13: -0.0123 T23: -0.0012 REMARK 3 L TENSOR REMARK 3 L11: 2.5897 L22: 9.1227 REMARK 3 L33: 5.1986 L12: -0.4482 REMARK 3 L13: -0.7292 L23: -2.7024 REMARK 3 S TENSOR REMARK 3 S11: 0.1982 S12: -0.2305 S13: 0.1592 REMARK 3 S21: -0.0291 S22: -0.2175 S23: -0.3920 REMARK 3 S31: -0.1403 S32: 0.2804 S33: 0.0193 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 482 A 530 REMARK 3 RESIDUE RANGE : A 561 A 659 REMARK 3 ORIGIN FOR THE GROUP (A): 14.7724 25.8299 2.9608 REMARK 3 T TENSOR REMARK 3 T11: 0.0223 T22: 0.0026 REMARK 3 T33: 0.0699 T12: 0.0056 REMARK 3 T13: -0.0038 T23: 0.0008 REMARK 3 L TENSOR REMARK 3 L11: 1.2502 L22: 1.1305 REMARK 3 L33: 1.3427 L12: 0.0415 REMARK 3 L13: -0.1688 L23: -0.0071 REMARK 3 S TENSOR REMARK 3 S11: 0.0003 S12: -0.0271 S13: 0.0433 REMARK 3 S21: 0.0033 S22: 0.0248 S23: 0.0403 REMARK 3 S31: -0.0518 S32: -0.0107 S33: -0.0251 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 7KXN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-DEC-20. REMARK 100 THE DEPOSITION ID IS D_1000253342. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-SEP-17 REMARK 200 TEMPERATURE (KELVIN) : 100.000 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X1A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99996 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 65405 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.340 REMARK 200 RESOLUTION RANGE LOW (A) : 59.350 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 4.540 REMARK 200 R MERGE (I) : 0.05800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.8100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.34 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.48 REMARK 200 R MERGE FOR SHELL (I) : 0.85200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.840 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: 1K2P REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.93 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 3350 0.1 M BIS TRIS PROPANE PH REMARK 280 7.5 0.2 M SODIUM ACETATE TRIHYDRATE, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 36.24850 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 51.67000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.24850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 51.67000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 393 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NE2 HIS A 635 OE1 GLU A 640 1.69 REMARK 500 CE1 HIS A 635 OE1 GLU A 640 1.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 424 -49.78 -136.58 REMARK 500 ARG A 520 -15.06 85.13 REMARK 500 ASP A 521 52.18 -147.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue X9P A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 703 DBREF 7KXN A 393 659 UNP Q06187 BTK_HUMAN 427 693 SEQRES 1 A 267 GLY SER TRP GLU ILE ASP PRO LYS ASP LEU THR PHE LEU SEQRES 2 A 267 LYS GLU LEU GLY THR GLY GLN PHE GLY VAL VAL LYS TYR SEQRES 3 A 267 GLY LYS TRP ARG GLY GLN TYR ASP VAL ALA ILE LYS MET SEQRES 4 A 267 ILE LYS GLU GLY SER MET SER GLU ASP GLU PHE ILE GLU SEQRES 5 A 267 GLU ALA LYS VAL MET MET ASN LEU SER HIS GLU LYS LEU SEQRES 6 A 267 VAL GLN LEU TYR GLY VAL CYS THR LYS GLN ARG PRO ILE SEQRES 7 A 267 PHE ILE ILE THR GLU TYR MET ALA ASN GLY CYS LEU LEU SEQRES 8 A 267 ASN TYR LEU ARG GLU MET ARG HIS ARG PHE GLN THR GLN SEQRES 9 A 267 GLN LEU LEU GLU MET CYS LYS ASP VAL CYS GLU ALA MET SEQRES 10 A 267 GLU TYR LEU GLU SER LYS GLN PHE LEU HIS ARG ASP LEU SEQRES 11 A 267 ALA ALA ARG ASN CYS LEU VAL ASN ASP GLN GLY VAL VAL SEQRES 12 A 267 LYS VAL SER ASP PHE GLY LEU SER ARG TYR VAL LEU ASP SEQRES 13 A 267 ASP GLU TYR THR SER SER VAL GLY SER LYS PHE PRO VAL SEQRES 14 A 267 ARG TRP SER PRO PRO GLU VAL LEU MET TYR SER LYS PHE SEQRES 15 A 267 SER SER LYS SER ASP ILE TRP ALA PHE GLY VAL LEU MET SEQRES 16 A 267 TRP GLU ILE TYR SER LEU GLY LYS MET PRO TYR GLU ARG SEQRES 17 A 267 PHE THR ASN SER GLU THR ALA GLU HIS ILE ALA GLN GLY SEQRES 18 A 267 LEU ARG LEU TYR ARG PRO HIS LEU ALA SER GLU LYS VAL SEQRES 19 A 267 TYR THR ILE MET TYR SER CYS TRP HIS GLU LYS ALA ASP SEQRES 20 A 267 GLU ARG PRO THR PHE LYS ILE LEU LEU SER ASN ILE LEU SEQRES 21 A 267 ASP VAL MET ASP GLU GLU SER HET X9P A 701 40 HET DMS A 702 4 HET DMS A 703 4 HETNAM X9P 3-TERT-BUTYL-N-[(1S)-6-{2-[5-METHYL-1-(PROPAN-2-YL)-1H- HETNAM 2 X9P PYRAZOL-4-YL]-1H-IMIDAZO[4,5-B]PYRIDIN-7-YL}-1,2,3,4- HETNAM 3 X9P TETRAHYDRONAPHTHALEN-1-YL]-1,2,4-OXADIAZOLE-5- HETNAM 4 X9P CARBOXAMIDE HETNAM DMS DIMETHYL SULFOXIDE FORMUL 2 X9P C30 H34 N8 O2 FORMUL 3 DMS 2(C2 H6 O S) FORMUL 5 HOH *270(H2 O) HELIX 1 AA1 ASP A 398 LYS A 400 5 3 HELIX 2 AA2 SER A 438 MET A 450 1 13 HELIX 3 AA3 CYS A 481 GLU A 488 1 8 HELIX 4 AA4 MET A 489 ARG A 492 5 4 HELIX 5 AA5 GLN A 494 LYS A 515 1 22 HELIX 6 AA6 ALA A 523 ARG A 525 5 3 HELIX 7 AA7 GLY A 541 VAL A 546 5 6 HELIX 8 AA8 ASP A 548 SER A 553 1 6 HELIX 9 AA9 PRO A 560 SER A 564 5 5 HELIX 10 AB1 PRO A 565 SER A 572 1 8 HELIX 11 AB2 SER A 575 SER A 592 1 18 HELIX 12 AB3 THR A 602 GLN A 612 1 11 HELIX 13 AB4 SER A 623 CYS A 633 1 11 HELIX 14 AB5 LYS A 637 ARG A 641 5 5 HELIX 15 AB6 THR A 643 GLU A 658 1 16 SHEET 1 AA1 5 LEU A 402 GLY A 411 0 SHEET 2 AA1 5 GLY A 414 TRP A 421 -1 O TYR A 418 N LYS A 406 SHEET 3 AA1 5 TYR A 425 MET A 431 -1 O ILE A 429 N LYS A 417 SHEET 4 AA1 5 PHE A 471 THR A 474 -1 O ILE A 472 N LYS A 430 SHEET 5 AA1 5 LEU A 460 CYS A 464 -1 N GLY A 462 O ILE A 473 SHEET 1 AA2 2 CYS A 527 VAL A 529 0 SHEET 2 AA2 2 VAL A 535 VAL A 537 -1 O LYS A 536 N LEU A 528 CISPEP 1 ARG A 468 PRO A 469 0 1.50 SITE 1 AC1 17 LEU A 408 GLY A 411 PHE A 413 VAL A 416 SITE 2 AC1 17 ALA A 428 LYS A 430 GLU A 475 TYR A 476 SITE 3 AC1 17 MET A 477 GLY A 480 ASN A 526 LEU A 528 SITE 4 AC1 17 ASP A 539 HOH A 870 HOH A 904 HOH A 943 SITE 5 AC1 17 HOH A 964 SITE 1 AC2 6 MET A 489 ARG A 492 SER A 553 SER A 554 SITE 2 AC2 6 SER A 572 HOH A1058 SITE 1 AC3 4 THR A 403 PHE A 404 TYR A 631 HOH A 910 CRYST1 72.497 103.340 38.619 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013794 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009677 0.000000 0.00000 SCALE3 0.000000 0.000000 0.025894 0.00000